Literature DB >> 16935897

Effect of dialysis membrane biocompatibility on polymorphonuclear granulocyte activity in dialysis patients.

Giuliana Banche1, Valeria Allizond, Franca Giacchino, Narcisa Mandras, Janira Roana, Franco Bonello, Paola Belardi, Vivian Tullio, Chiara Merlino, Nicola Carlone, Anna Maria Cuffini.   

Abstract

BACKGROUND: Among patients with defects of the phagocytic component of the immune system, chronic haemodialysis patients are highly susceptible to microbial infections characterized by high morbidity/mortality, related to an impairment of the phagocytic response. Therefore the potential influence of dialysis membrane biocompatibility on the activity of polymorphonuclear (PMN) granulocytes from dialysis patients was investigated in this study.
METHODS: Nineteen patients in haemodialysis were included in the protocol and divided into two groups: a control group (7 patients) and a study group (12 patients). The study group patients were treated for subsequent periods of 1 month with different dialysis membranes: low flux excebrane E membrane (CL-E), low flux polysulfone (PS). The control group patients were treated with a low flux modified cellulose membrane (SMC) for the entire observation period. The aetiology of end-stage renal disease included glomerulonephritis, nephroangiosclerosis and interstitial nephropathy. Following each period of treatment, clinical and haematological parameters were evaluated; phagocytosis and microbicidal activity of PMNs from uraemic patients against Klebsiella pneumoniae, the pathogen which can pose severe problems in immune depressed patients, were investigated in parallel.
RESULTS: The data evidence that both clinical and haematological parameters remained unchanged during the study period and no differences were found among treatments. On the contrary, the PMN activity varied according to the type of the membrane. In fact, the use of both PS and CL-E, in contrast to SMC, resulted in a PMN functionality similar to that observed in healthy subjects.
CONCLUSIONS: These results provide evidence that the depressed PMN activities in dialysis patients may be influenced by membrane biocompatibility in such a way to be totally restored.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935897     DOI: 10.1093/ndt/gfl415

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  Candida albicans infections in renal transplant recipients: effect of caspofungin on polymorphonuclear cells.

Authors:  Valeria Allizond; Giuliana Banche; Franca Giacchino; Chiara Merlino; Daniela Scalas; Vivian Tullio; Giuseppe Garneri; Narcisa Mandras; Janira Roana; Anna Maria Cuffini
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

2.  Long-term follow-up characteristics of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving chronic hemodialysis at a single center.

Authors:  Yoei Miyabe; Kazunori Karasawa; Tomo Takabe; Shota Ogura; Naoko Sugiura; Mizuki Kyoda; Wataru Ono; Kenichi Akiyama; Nobue Tanaka; Takahito Moriyama; Norio Hanafusa; Keiko Uchida; Ken Tuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2019-10-22       Impact factor: 2.801

3.  Synergy of caspofungin with human polymorphonuclear granulocytes for killing Candida albicans.

Authors:  Vivian Tullio; Narcisa Mandras; Daniela Scalas; Valeria Allizond; Giuliana Banche; Janira Roana; Deborah Greco; Franco Castagno; Anna Maria Cuffini; Nicola A Carlone
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

4.  Low-density lipoprotein (LDL) apheresis reduces atherogenic and oxidative markers in uremic patients with hyperlipidemia.

Authors:  Tung-Sheng Chen; Show-Yih Liou; Hsi-Chin Wu; Fuu-Jen Tsai; Chang-Hai Tsai; Chih-Yang Huang; Yen-Lin Chang
Journal:  Int Urol Nephrol       Date:  2010-03-14       Impact factor: 2.370

5.  Dialyzer Reuse and Outcomes of High Flux Dialysis.

Authors:  Christos Argyropoulos; Maria-Eleni Roumelioti; Abdus Sattar; John A Kellum; Lisa Weissfeld; Mark L Unruh
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

6.  Leukocyte proliferation and immune modulator production in patients with chronic kidney disease.

Authors:  Ladan Mansouri; Josefin M Paulsson; Ali Moshfegh; Stefan H Jacobson; Joachim Lundahl
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

7.  Activation of basophils is a new and sensitive marker of biocompatibility in hemodialysis.

Authors:  Zenib Aljadi; Ladan Mansouri; Anna Nopp; Josefin M Paulsson; Ola Winqvist; Aman Russom; Mårten Ståhl; Britta Hylander; Stefan H Jacobson; Joachim Lundahl
Journal:  Artif Organs       Date:  2014-04-09       Impact factor: 3.094

8.  Evaluation of neutrophil function during hemodialysis treatment in healthy dogs under anesthesia with sevoflurane.

Authors:  Shunsuke Shimamura; Ken Kimura; Masaaki Katayama; Tadahisa Mashita; Kenichi Maeda; Saori Kobayashi; Reeko Sato; Jun Yasuda
Journal:  J Vet Med Sci       Date:  2014-08-21       Impact factor: 1.267

9.  Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO.

Authors:  Tanushree Banerjee; Timothy W Meyer; Tariq Shafi; Thomas H Hostetter; Michal Melamed; Yunnuo Zhu; Neil R Powe
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.